This inventor holds 2 USPTO granted patents. Top assignees: Leland Stanford Junior University, Versitech, Inc.. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 5,519 
2 out of 144 Years Active: 2014-2016
Title: Yu-Lung Lau: Inventor in Therapeutic Regulatory T-Cell Research.
Introduction
Yu-Lung Lau is an inventor associated with Hong Kong, CN. His patent work includes methods for inducing and expanding alloantigen-specific human regulatory T cells for potential therapeutic applications. His portfolio includes 2 patents.
Latest Patents
Lau’s listed patent, “Method to Induce and Expand Therapeutic Alloantigen-Specific Human Regulatory T Cells in Large-Scale,” describes methods for inducing, expanding, or generating alloantigen-specific regulatory T cells from naive CD4+CD25− T cells using CD40-activated B cells. The disclosed cells may be human regulatory T cells, including CD4+CD25+Foxp3+ cells. The supplied patent information lists this title and description twice.
Career Highlights
Lau is associated with Versitech, Inc. and Leland Stanford Junior University. His patent work focuses on approaches to producing alloantigen-specific regulatory T cells at scale, a subject relevant to therapeutic cell research.
Collaborations
The supplied information identifies David Bram Lewis and Wenwei Tu as Lau’s coworkers.
Conclusion
Yu-Lung Lau’s listed inventions center on methods for generating and expanding therapeutic alloantigen-specific regulatory T cells, reflecting his contributions to patent activity in this area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile